A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

This study has been completed.

Sponsor:

Information provided by:

Merck

ClinicalTrials.gov Identifier:

NCT00482235

First received: June 1, 2007

Last updated: NA

Last verified: June 2007

History: No changes posted

Tracking Information

First Received Date ^ICMJE

June 1, 2007

Last Updated Date

June 1, 2007

Start Date ^ICMJE

December 2002

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

Not Provided

Original Primary Outcome Measures ^ICMJE

Not Provided

Change History

No Changes Posted

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Official Title ^ICMJE

Not Provided

Brief Summary

A study to test the effect of MK0359 in lessening the symptoms of COPD as compared to salmeterol and placebo.

Detailed Description

Not Provided

Study Type ^ICMJE

Interventional

Study Phase

Phase 2

Study Design ^ICMJE

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment

Condition ^ICMJE

Pulmonary Disease, Chronic Obstructive

Intervention ^ICMJE

Drug: MK0359

Study Arm (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Not Provided

Completion Date

Not Provided

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Inclusion Criteria:

You are between the ages of 40 and 75
You have had a history for at least a year of COPD symptoms
You have a history of smoking one pack of cigarettes per day for 10 years

Exclusion Criteria:

You have been in a research study with an investigational drug or vaccine in the last 4 weeks.
You have donated blood in the last 4 weeks.
You have been hospitalized or had major surgery in the last 4 weeks
You have been treated in the emergency room within the last 2 months or hospitalized within the last 3 months for your COPD symptoms
You have a history of heart problems in the last 6 months
You have a history of stomach problems
You are unwilling to avoid grapefruit juice throughout the study

Gender

Both

Ages

40 Years to 75 Years

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

Not Provided

Administrative Information

NCT Number ^ICMJE

NCT00482235

Other Study ID Numbers ^ICMJE

2007_569

Has Data Monitoring Committee

Not Provided

Responsible Party

Not Provided

Study Sponsor ^ICMJE

Merck

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Study Director:

Medical Monitor

Merck

Information Provided By

Merck

Verification Date

June 2007

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top